PROMETRIKA, LLC

A Full-Service Clinical Research Organization

Apr 17 2015

PROMETRIKA Supports Advanced Research in MS

Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system (CNS). It is hypothesized that CNS auto-reactive T cells are stimulated in the peripheral circulation to become active and proliferate, with subsequent migration into the CNS compartment. These cells, upon interacting with CNS myelin antigens, again proliferate and initiate a pro-inflammatory cascade within the brain that results in damage. Continue reading “PROMETRIKA Supports Advanced Research in MS”

Mar 11 2015

PROs: Ground to Cloud in 10 Years

M. Alexandra Rohall, Sr. Manager, Medical Writing, PROMETRIKA LLC

Patient-reported outcome (PRO) instruments, such as patient-completed (or interviewer-administered) diaries, questionnaires, and visual analog scales (VAS), have been a part of clinical research for many years. The sponsor’s objective in using PRO instruments is to measure the clinical effects of treatment, especially for parameters that are difficult to measure objectively, like pain. Continue reading “PROs: Ground to Cloud in 10 Years”

Internet Explorer has detected you are viewing this page in Compatibility View. PROMETRIKA.COM works best if you turn this off.

 

Please change to normal view by clicking on Tools and then Compatibility View